Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Livedoid Vasculitis”

84 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 84 results

Not applicableStudy completedNCT05878327
What this trial is testing

Livedoid Vasculopathy: Strong Association With Smoking, Weak Association With Thrombophilia

Who this might be right for
Livedoid Vasculitis
University of Zurich 15
Not applicableUnknownNCT01378845
What this trial is testing

Prognostic Influence of Light Rheography Measurement of Patients With Secondary Raynaud Syndrome With Ulcers on Hands

Who this might be right for
Raynaud's PhenomenonSkin Necrosis
Christoph Hehrlein 30
Testing effectiveness (Phase 2)Study completedNCT00528242
What this trial is testing

Safety, Tolerability, and Pharmacodynamic Profile of Oral 2101 in Secondary Raynaud's Disease

Who this might be right for
Raynaud's Disease
Response Pharmaceuticals 17
Not applicableStudy completedNCT04644523
What this trial is testing

Dermoscopy in Primary Raynaud's Phenomenon

Who this might be right for
Raynaud Phenomenon
Assistance Publique - Hôpitaux de Paris 100
Large-scale testing (Phase 3)Study completedNCT01280266
What this trial is testing

Efficacy Study of PDE-5 Inhibitor and Calcium Channel Inhibitor for the Treatment of Secondary Raynaud Phenomenon

Who this might be right for
Raynaud Phenomenon
Seoul National University Hospital 29
Not applicableEnded earlyNCT02642146
What this trial is testing

Treatment of Digital Ulcers in Korean Patients With Systemic Sclerosis: a Prospective Cohort Study

Who this might be right for
Raynaud DiseaseSystemic SclerosisDigital Ulcer
Seoul National University Hospital 71
Not applicableStudy completedNCT03058887
What this trial is testing

The Effects of Exercise in Patients With Systemic Sclerosis

Who this might be right for
Systemic SclerosisRaynaud's PhenomenonQuality of Life
Sheffield Hallam University 36
Not applicableEnded earlyNCT02298777
What this trial is testing

Metabolomic Analysis of Systemic Sclerosis

Who this might be right for
Scleroderma (Limited and Diffuse)Undifferentiated Connective Tissue DiseaseRaynaud Disease+2 more
University Hospital, Strasbourg, France 121
Not applicableStudy completedNCT05094687
What this trial is testing

Cutaneous Manifestations of Coronavirus Disease 2019(COVID-19).

Who this might be right for
Cutaneous ManifestationsSkin ManifestationsCOVID-19+5 more
Jinnah Postgraduate Medical Centre 1,206
Large-scale testing (Phase 3)Not Yet RecruitingNCT05698979
What this trial is testing

Evaluation of Botulinum TOXin Type A in the Treatment of Buerger's Disease

Who this might be right for
Buerger DiseaseRaynaud Syndrome
University Hospital, Toulouse 8
Large-scale testing (Phase 3)Study completedNCT01347008
What this trial is testing

Effect of Sildenafil on the Microcirculatory Blood Flow and Endothelial Progenitor Cells in Systemic Sclerosis

Who this might be right for
Scleroderma, SystemicScleroderma, DiffuseScleroderma, Limited+1 more
Federal University of São Paulo 41
Not applicableStudy completedNCT06291142
What this trial is testing

Early Diagnosis of SSc in the General Rheumatology Clinic - Pilot

Who this might be right for
Systemic SclerosisRaynaud Phenomenon
University of Manchester 112
Not applicableStudy completedNCT02396238
What this trial is testing

Scleroderma Treatment With Celution Processed Adipose Derived Regenerative Cells (STAR)

Who this might be right for
SclerodermaSystemic SclerosisRaynaud Phenomena+1 more
Cytori Therapeutics 88
Large-scale testing (Phase 3)Study completedNCT00351117
What this trial is testing

St. John's Wort in the Treatment of Raynaud's Phenomenon

Who this might be right for
Raynaud's Disease
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 20
Large-scale testing (Phase 3)Study completedNCT00626665
What this trial is testing

Randomised Control Trial to Assess the Efficacy of Tadalafil in Raynaud's Phenomenon in Scleroderma

Who this might be right for
Raynaud Disease
Sanjay Gandhi Postgraduate Institute of Medical Sciences 25
Large-scale testing (Phase 3)Study completedNCT00253331
What this trial is testing

Lab Study of MQX-503 in Treatment of Raynaud's

Who this might be right for
Raynaud DiseaseRaynaud Disease Secondary to SclerodermaRaynaud Secondary to Other Autoimmune Disease
MediQuest Therapeutics 36
Large-scale testing (Phase 3)Study completedNCT00004786
What this trial is testing

Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Iloprost for Raynaud's Phenomenon Secondary to Systemic Sclerosis

Who this might be right for
Systemic SclerosisRaynaud Disease
National Center for Research Resources (NCRR) 200
Large-scale testing (Phase 3)Study completedNCT02165111
What this trial is testing

Efficacy of Botulinum Toxin In Scleroderma-Associated Raynaud's Syndrome

Who this might be right for
SclerodermaRaynaud's Syndrome
Johns Hopkins University 40
Testing effectiveness (Phase 2)Study completedNCT01309802
What this trial is testing

A Two-Part Study of BOTOX® Therapy for Ischemic Digits

Who this might be right for
Raynaud's Disease
Southern Illinois University 48
Testing effectiveness (Phase 2)Study completedNCT00480753
What this trial is testing

Dose Response Study of a Topical Formulation of Nitroglycerin for the Treatment of Raynaud's Phenomenon

Who this might be right for
Raynaud's Disease
MediQuest Therapeutics 15
Next Page